Characteristics of newly admitted COPD Patients with closed and open Triple Therapy in Germany

被引：0
|
作者：
Beeh, M. K. [1 ]
Rothnie, K. [2 ]
Hardtstock, F. [3 ]
Claussen, J. [4 ]
Knapp, R. [3 ]
Wilke, T. [5 ]
Czira, A. [2 ]
Comptom, C. [6 ]
Sharma, R. [6 ]
Ismaila, A. [2 ]
机构：
[1] Insaf Resp Res Inst, Wiesbaden, Germany
[2] GlaxoSmithKline, Value Evidence & Outcomes, R&D Global Med, Brentford, England
[3] Cytel Ingress Hlth, Wismar, Germany
[4] Gsk Deutschland, Munich, Germany
[5] Ipam eV, Wismar, Germany
[6] GlaxoSmithKline, Global Med, Brentford, England
来源：
PNEUMOLOGIE | 2022年 / 76卷
关键词：
D O I：
10.1055/s-0042-1747801
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 252
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] CLINICAL CHARACTERISTICS OF PATIENTS ADMITTED FOR ACUTE EXACERBATION OF COPD THAT PREDICT SHORTER LENGTH OF STAY
    Cerasale, Matthew
    Mroue, Khalil
    Castillo, Juan Cesar Fernandez
    Swiderek, Jennifer
    Paje, David
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S50 - S50
  • [42] Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study
    Bogart, Michael
    Stanford, Richard H.
    Reinsch, Tyler
    Hull, Michael
    Buikema, Ami
    Hulbert, Erin
    RESPIRATORY MEDICINE, 2018, 142 : 73 - 80
  • [43] Closed pelvic fractures: characteristics and outcomes in older patients admitted to medical and geriatric wards
    Morris, RO
    Sonibare, A
    Green, DJ
    Masud, T
    POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (900) : 646 - 650
  • [44] Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy
    Numbere, Beade
    Liu, Yunhao
    Zhang, Shiyuan
    Czira, Alexandrosz
    Lu, Yifei
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [45] A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
    Huang, Wei-Chun
    Chen, Chih-Yu
    Liao, Wei-Chih
    Wu, Biing-Ru
    Chen, Wei-Chun
    Tu, Chih-Yen
    Chen, Chia-Hung
    Cheng, Wen-Chien
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1555 - 1568
  • [46] Cluster analysis on breath print of newly diagnosed COPD patients: effects of therapy
    Scarlata, Simone
    Finamore, Panaiotis
    Santangelo, Simona
    Giannunzio, Gilda
    Pennazza, Giorgio
    Grasso, Simone
    Santonico, Marco
    Incalzi, Raffaele Antonelli
    JOURNAL OF BREATH RESEARCH, 2018, 12 (03)
  • [47] Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain
    Alcazar-Navarrete, Bernardino
    Garcia-Rio, Francisco
    Sanchez, Guadalupe
    Mariscal, Esther
    Garcia, Andrea
    Cuesta, Maribel
    Uria, Estefany
    Miravitlles, Marc
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 2149 - 2161
  • [48] Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: A pilot study
    Pasqua, Franco
    Biscione, Gianluca
    Crigna, Girolmina
    Auciello, Laura
    Cazzola, Mario
    RESPIRATORY MEDICINE, 2010, 104 (03) : 412 - 417
  • [49] Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)
    Miyazaki, M.
    Nakamura, H.
    Sasaki, M.
    Haraguchi, M.
    Chubachi, S.
    Takahashi, S.
    Yoshida, S.
    Shirahata, T.
    Asano, K.
    Betsuyaku, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] Roflumilast added to triple therapy in patients with severe COPD: A real life study
    Munoz-Esquerre, Mariana
    Diez-Ferrer, Marta
    Monton, Concepcion
    Pomares, Xavier
    Lopez-Sanchez, Marta
    Huertas, Daniel
    Manresa, Frederic
    Dorca, Jordi
    Santos, Salud
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 30 : 16 - 21
12345